Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-01-07 @ 11:25 PM
Study NCT ID:
NCT03671460
Status:
UNKNOWN
Last Update Posted:
2018-09-14
First Post:
2018-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.
Sponsor:
Tianjin Mycure Medical Technology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-09-11
First Submit QC Date:
None
Study First Post Date:
2018-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-13
Last Update Post Date:
2018-09-14
Last Update Post Date Type:
ACTUAL